12.06.2014 Views

Dermal Sensitization QRA Approach for Fragrance Ingredient

Dermal Sensitization QRA Approach for Fragrance Ingredient

Dermal Sensitization QRA Approach for Fragrance Ingredient

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

QUANTITATIVE RISK<br />

ASSESSMENT (<strong>QRA</strong>) FOR<br />

INDUCTION OF THE DERMAL<br />

SENSITIZATION FOR FRAGRANCE<br />

INGREDIENTS: ITS PRACTICAL<br />

APPLICATION<br />

Anne Marie Api, PhD<br />

Research Institute <strong>for</strong> <strong>Fragrance</strong> Materials, Inc.<br />

Vice President, Human Health Sciences<br />

<strong>QRA</strong> Implementation Workshop<br />

January 23, 2007


Contact Dermatitis, 2001, 45,<br />

333-340<br />

<strong>Dermal</strong> <strong>Sensitization</strong> Quantitative Risk Assessment (<strong>QRA</strong>)<br />

For <strong>Fragrance</strong> <strong>Ingredient</strong>s<br />

Technical Dossier<br />

March 15, 2006<br />

Revised May 26, 2006<br />

The group recommended an<br />

exposure-based <strong>QRA</strong> methodology<br />

<strong>for</strong> fragrance ingredients …now<br />

implemented<br />

Api <strong>QRA</strong> Worksop Jan 2007<br />

Revised June 22,2006<br />

<strong>QRA</strong> Expert Group<br />

Anne Marie Api (RIFM), David A. Basketter (SEAC, Unilever),<br />

Peter A. Cadby (Firmenich), Marie-France Cano (LVMH),<br />

Graham Ellis (Givaudan), G. Frank Gerberick (Procter &<br />

Gamble), Peter Griem (Clariant Produkte GmbH), Pauline M.<br />

McNamee (Procter & Gamble), Cindy A. Ryan (Procter &<br />

Gamble) and Bob Saf<strong>for</strong>d (SEAC, Unilever)


<strong>QRA</strong> IMPLEMENTATION STATUS<br />

• Technical dossier published on RIFM website<br />

www.rifm.org/pub/publications.asp<br />

• In<strong>for</strong>mational booklet issued May 2006 on RIFM<br />

website<br />

www.rifm.org/pub/publications.asp<br />

• 40 th Amendment May 2006 - Citral, Farnesol,<br />

Phenylacetaldehyde, Tea Leaf Absolute<br />

• Publications in peer reviewed journals - in<br />

preparation<br />

• Publications in trade press – in preparation<br />

• Implementation guidance - users & customers -<br />

ongoing<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> FOR DERMAL SENSITIZATION<br />

FRAGRANCE INGREDIENTS<br />

Application to induction of skin sensitization - a threshold<br />

phenomenon<br />

• Determine potential (hazard) to induce sensitization:<br />

• Pre-clinical studies e.g. Guinea-Pig Test, LLNA<br />

• Human data (historical)<br />

• Structure based predictive approach<br />

• Dose response:<br />

• Determine the No-Expected-<strong>Sensitization</strong> Induction-Level (NESIL)<br />

based on the Weight of Evidence (WoE)<br />

• Calculate <strong>Sensitization</strong> Assessment Factor (SAF)<br />

• Exposure:<br />

• Dose metric: expressed in Dose/Area<br />

• Understand consumer exposure expressed as product<br />

categories<br />

• How consumers are exposed: amount, duration and frequency<br />

• Risk characterization:<br />

Acceptable Exposure Level = WoE NESIL<br />

(AEL)<br />

(SAF)<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> FOR DERMAL SENSITIZATION<br />

FRAGRANCE INGREDIENTS: WHAT’S S NEW<br />

• NESIL - No Expected<br />

<strong>Sensitization</strong><br />

Induction<br />

Level<br />

• Establishment of scientifically sound NESILs is key<br />

• Weight of evidence approach to use of data<br />

• Identifies studies inappropriate <strong>for</strong> consideration<br />

• Can be derived from animal and human data<br />

• SAF – <strong>Sensitization</strong> Assessment Factor<br />

• Greater understanding of different elements comprising<br />

overall SAF<br />

• Extrapolation from controlled experimental situation to<br />

real life exposure scenarios<br />

• Detailed scientific rationale <strong>for</strong> SAF determination<br />

• Exposure<br />

• Consistent use of the same dose metric (μg/cm 2 )<br />

• Sources of exposure data in calculation of exposure to<br />

fragrance ingredients in consumer products<br />

Api <strong>QRA</strong> Worksop Jan 2007


CITRAL<br />

• Hazard Identification<br />

• Guinea pig data - weak sensitizer [14]<br />

• Local Lymph Node Assay<br />

• EC 3 = 1414 µg/cm 2 [11]<br />

• LOEL<br />

• HRIPT: 3876 µg/cm 2 in EtOH 5/8<br />

• HMT: 2759 µg/cm 2 in pet. 29/150<br />

• Other Data<br />

• 1240 µg/cm 2 in pet. 0/50<br />

• 775 µg/cm 2 in EtOH 0/41<br />

• 338 µg/cm 2 in EtOH 0/40<br />

• Confirmatory HRIPT - NOEL<br />

• 1400 µg/cm 2 in 3:1 DEP:EtOH 0/101<br />

Api <strong>QRA</strong> Worksop Jan 2007


EXPOSURE DATA (DOSE/AREA)<br />

Product Type<br />

Source<br />

Exposure<br />

mg/cm 2 /day<br />

Deo/AP Solid<br />

CTFA<br />

8.5<br />

Hydroalcoholic, Unshaved<br />

Women’s Facial Cream<br />

Cano & Rich*<br />

Colipa<br />

2.2<br />

0.2<br />

Shaving Cream SCCP 0.07<br />

Eye Product<br />

Body Cream<br />

Lip Products<br />

Hair Sprays<br />

Toothpaste<br />

CTFA<br />

Colipa<br />

Colipa<br />

CTFA<br />

Colipa<br />

2.17<br />

0.5<br />

11.7<br />

2.2<br />

0.13<br />

Mouthwash SCCP 1.4<br />

Shampoo<br />

Body Wash/Gels<br />

CTFA<br />

SCCP<br />

0.2<br />

0.01<br />

Api <strong>QRA</strong> Worksop Jan 2007<br />

*Cano & Rich, 2001; Tozer et al., 2004


CONSUMER EXPOSURE LEVEL<br />

Exposure assessment <strong>for</strong> shampoos:<br />

• Calculated exposure = 23,630 mg/day<br />

(CTFA)<br />

• Area = 1430 cm 2 (EPA, 1997; area hands +<br />

½ head)<br />

• Retention Factor = 1% or 0.01 (SCCNFP,<br />

2003)<br />

Exposure = 23,630 mg/day * 0.01 ÷ 1430 cm 2<br />

= 0.2 mg/cm 2 /day<br />

Api <strong>QRA</strong> Worksop Jan 2007


RISK CHARACTERIZATION FOR<br />

FRAGRANCE INGREDIENTS<br />

• Acceptable Exposure Levels (AELs) to<br />

fragrance ingredients that are dermal<br />

sensitizers can be determined in specific real<br />

life consumer product types<br />

Acceptable<br />

Exposure Level (AEL) <strong>Sensitization</strong><br />

Assessment Factor<br />

(SAF)<br />

• Comparison of Acceptable Exposure Levels<br />

(AEL) to calculated Consumer Exposure<br />

Level (CEL)<br />

Api <strong>QRA</strong> Worksop Jan 2007<br />

=<br />

WoE NESIL<br />

AEL > CEL to be Acceptable


<strong>QRA</strong> DERMAL SENSITIZATION<br />

CITRAL<br />

Weight of Evidence NESIL<br />

•Guinea-pig data – weak sensitizer<br />

•Local Lymph Node Assay<br />

EC 3<br />

= 1414 µg/cm 2 [11]<br />

•Human data<br />

HRIPT NOEL = 1400 µg/cm 2<br />

•Weight of Evidence NESIL = 1400 µg/cm 2<br />

<strong>Sensitization</strong> Assessment<br />

Factors<br />

•Considerations<br />

Inter-individual variability<br />

Product matrix differences<br />

Variations in use patterns<br />

•Hydroalcoholic Unshaved SAF is 100<br />

•Deo/AP SAF is 300<br />

Api <strong>QRA</strong> Worksop Jan 2007<br />

Exposure<br />

•Consumer exposure<br />

Hydroalcoholic (unshaved<br />

skin) = 2.2 mg/cm 2<br />

AEL = 1400/100<br />

= 14.0 µg/cm 2<br />

AEL/CEL<br />

(14.0 ug/cm 2 X 0.001<br />

mg/µg) ÷ 2.2 mg/cm 2 /day<br />

= 0.0064<br />

AEL≥CEL ≤ 0.64%<br />

•Consumer exposure<br />

DEO/AP = 8.5mg/cm 2<br />

AEL = 1400/300<br />

= 4.7 µg/cm2<br />

AEL/CEL = 0.0005<br />

AEL≥CEL ≤ 0.05%


<strong>QRA</strong> DERMAL SENSITIZATION<br />

CITRAL IN A HYDROALCOHOLIC<br />

UNSHAVED SKIN - INDUCTION<br />

0.6%<br />

13 μg/cm 2 1.7%<br />

CEL 37 μg/cm 2<br />

CEL<br />

14<br />

μg/cm 2<br />

AEL<br />

1400<br />

μg/cm 2<br />

WoE NESIL<br />

AEL/CEL Acceptable<br />

SAF = 100<br />

AEL/CEL<br />

Unacceptable<br />

0.01 0. 1 1.0 10 100 1000 10,000<br />

Citral Level - log μg/cm 2<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> DERMAL SENSITIZATION<br />

CITRAL IN SOLID AP - INDUCTION<br />

0.05%<br />

4.3 μg/cm 2<br />

CEL<br />

4.7<br />

μg/cm 2<br />

AEL<br />

1400<br />

μg/cm 2<br />

Woe NESIL<br />

AEL/CEL Acceptable<br />

SAF = 300<br />

0.01 0. 1 1.0 10 100 1000 10,000<br />

Citral Level - log μg/cm 2<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> DERMAL SENSITIZATION<br />

CINNAMIC ALDEHYDE<br />

Weight of Evidence NESIL<br />

•Guinea-pig data – moderate sensitizer<br />

•Local Lymph Node Assay<br />

EC 3 = 280 µg/cm 2 [23]<br />

•Human data<br />

HRIPT NOEL = 591 µg/cm 2<br />

•Weight of Evidence NESIL = 590 µg/cm 2<br />

SAF<br />

•Considerations<br />

Inter-individual variability<br />

Product matrix differences<br />

Variations in use patterns<br />

•Deo/AP SAF is 300<br />

•Conditioners SAF is 100<br />

Exposure<br />

•Calculation <strong>for</strong> Daily<br />

Exposure to 0.05% CA (IFRA<br />

Standard):<br />

= [Amount of CA in<br />

product x Amount product<br />

applied (mg)]/Surface area<br />

exposed (cm 2 )<br />

•Consumer exposure<br />

Deo/AP=0.05% x 8.5<br />

mg/cm 2 = 4.3 µg/cm 2<br />

Conditioners = 0.05 % x<br />

0.2 mg/cm 2 = 0.1 µg/cm 2<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> DERMAL SENSITIZATION CINNAMIC<br />

ALDEHYDE IN SOLID AP - INDUCTION<br />

2.0 μg/cm<br />

2<br />

AEL<br />

0.02%<br />

1.7 μg/cm<br />

2<br />

CEL<br />

0.05%<br />

4.3 μg/cm<br />

2<br />

CEL<br />

590 μg/cm<br />

2<br />

WoE NESIL<br />

AEL/CEL Acceptable<br />

SAF = 300<br />

AEL/CEL<br />

Unacceptable<br />

0.001 0. 01 0.1 1.0 10 100 1000<br />

Cinnamic Aldehyde Level - log μg/cm<br />

2<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> DERMAL SENSITIZATION CINNAMIC<br />

ALDEHYDE IN CONDITIONERS - INDUCTION<br />

0.05%<br />

0.1 μg/cm 2<br />

CEL<br />

3.0% =<br />

5.8 μg/cm 2<br />

Potential<br />

Consumer<br />

exposure<br />

5.9<br />

μg/cm 2<br />

AEL<br />

590 μg/cm 2<br />

WoE NESIL<br />

AEL/CEL<br />

Acceptable<br />

SAF = 100<br />

0.001 0. 01 0.1 1.0 10 100 1000<br />

Cinnamic Aldehyde Level - log μg/cm<br />

2<br />

Api <strong>QRA</strong> Worksop Jan 2007


REFINEMENT RISK ASSESSMENT-<br />

SKIN SENSITIZATION<br />

RA<br />

Risk<br />

Mgmt<br />

Clinical<br />

Reports<br />

Api <strong>QRA</strong> Worksop Jan 2007


PATCH TEST DATABASE<br />

<strong>Fragrance</strong><br />

<strong>Ingredient</strong><br />

U. HOSPITAL LEUVEN<br />

2000-2005<br />

2005<br />

Product<br />

Type<br />

Positive Patch<br />

Test Reactions<br />

Cinnamic Deodorant 2<br />

Aldehyde<br />

Aftershave 1<br />

Isoeugenol<br />

Deodorant 1<br />

Hair Dye 1<br />

Hydroalcoholic 5<br />

Citral Hydroalcoholic 6<br />

303/3323 (9.1%) Positive to <strong>Fragrance</strong> Mix; 133/303 Positive to Own<br />

Cosmetic; 66/133 fragrance-related contact allergic reactions<br />

Api <strong>QRA</strong> Worksop Jan 2007


IFRA PRODUCT CATEGORIES<br />

IFRA Category<br />

Category 1<br />

Category 2<br />

Category 3<br />

Category 4<br />

Category 5<br />

Category 6<br />

Category 7<br />

Category 8<br />

Category 9<br />

Category 10<br />

Category 11<br />

BASED ON <strong>QRA</strong><br />

Examples of Products<br />

Lip Products, Toys, Insect Repellents<br />

Deodorants/Antiperspirants<br />

Hydroalcoholic Products <strong>for</strong> Shaved Skin, Eye Products,<br />

Men’s Facial Cream & Balms, Tampons<br />

Hydroalcoholic Products <strong>for</strong> Unshaved Skin, Hair Styling<br />

Aids & Sprays, Body Creams<br />

Women’s Facial Cream/Facial Make-up, Hand Cream, Facial<br />

Masks, Wipes/Refreshing Tissue <strong>for</strong> Hands, Face, Neck, Body<br />

Mouthwash, Toothpaste<br />

Intimate Wipes, Baby Wipes<br />

Make-up Remover, Hair Styling Aids Non-Spray, Nail Care<br />

Shampoo, Rinse-Off Conditioners, Bar Soap, Feminine<br />

Hygiene Pads & Liners<br />

Detergents, Hard Surface Cleaners, Diapers<br />

All Non-Skin or incidental skin contact products<br />

Api <strong>QRA</strong> Worksop Jan 2007


IFRA PRODUCT CATEGORY 11<br />

All non-skin contact or incidental skin<br />

contact. Including:<br />

Candles<br />

Air Fresheners and Fragrancing of all types (plug-ins, solid<br />

substrate, membrane delivery, ambient, electrical, pot<br />

pourri, powders, fragrancing sachets, incense, etc.)<br />

Deodorizers/Maskers Not Intended For Skin Contact (e.g.<br />

fabric drying machine deodorizers, carpet powders)<br />

Insecticides (e.g. mosquito coil, paper, electrical, etc.)<br />

Toilet Blocks; Joss Sticks; Shoe Polishes<br />

Machine Dishwash Detergent and Deodorizers<br />

Machine Only Laundry Detergent (e.g. liquitabs)<br />

Plastic articles (excluding toys)<br />

Fuels; Paints; Cat litter; Animal Sprays<br />

Treated Textiles (e.g. starch sprays, fabric treated with<br />

fragrances after wash, deodorizers <strong>for</strong> textiles or fabrics,<br />

tights with moisturizers)<br />

Odored Distilled Water (that can be added to steam irons)<br />

Floor wax<br />

Api <strong>QRA</strong> Worksop Jan 2007<br />

Pragmatic<br />

Level<br />

These<br />

products<br />

result in<br />

negligible<br />

skin contact.<br />

The approach<br />

<strong>for</strong> a<br />

pragmatic<br />

concentration<br />

of fragrance<br />

ingredient in<br />

this category<br />

is explained<br />

in IFRA RIFM<br />

Booklet


IFRA PRODUCT CATEGORY 5<br />

SAF<br />

Product Type<br />

Consumer<br />

Exposure<br />

Level<br />

mg/cm 2 /day<br />

100 Facial Cream/Make-up 3.17<br />

100 Hand Cream 4.2<br />

IFRA<br />

Category 5<br />

Consumer<br />

Exposure<br />

4.2<br />

Api <strong>QRA</strong> Worksop Jan 2007


IFRA PRODUCT CATEGORIES<br />

BASED ON <strong>QRA</strong><br />

IFRA<br />

Category<br />

SAF<br />

Category Consumer Exposure<br />

mg/cm 2 /day<br />

Product Type Designating<br />

IFRA Category<br />

Category 1<br />

Category 2<br />

Category 3<br />

Category 4<br />

300 11.7 Lipstick<br />

300 8.5 Solid Antiperspirant<br />

300 2.2 Aftershave<br />

100 2.2 Perfume<br />

Category 5<br />

Category 6<br />

Category 7<br />

Category 8<br />

Category 9<br />

Category 10<br />

Category 11<br />

100<br />

100<br />

300<br />

100<br />

100<br />

100<br />

10<br />

4.2<br />

1.4<br />

4.4<br />

1.0<br />

0.2<br />

0.1<br />

0.00033<br />

Hand Cream<br />

Toothpaste<br />

Intimate Wipes<br />

Hair Styling Aids<br />

Conditioners, Rinse-Off<br />

Hard Surface Cleaners<br />

Candles<br />

Api <strong>QRA</strong> Worksop Jan 2007


IFRA STANDARD LIMITS FOR<br />

CITRAL BASED ON <strong>QRA</strong><br />

IFRA<br />

Cat.<br />

Examples of Product Type<br />

Citral<br />

<strong>QRA</strong><br />

1 Lip Products 0.04%<br />

2 Deodorant/Antiperspirant 0.05%<br />

3 Hydroalc., Shaved Skin 0.2%<br />

4 Hydroalc., Unshaved Skin 0.6%<br />

5 Women Facial Cream 0.3%<br />

6 Mouthwash 1.0%<br />

7 Intimate Wipes 0.1%<br />

8 Hair Styling Aids Non-Spray 1.4%<br />

9 Conditioners, Rinse-off 5.0%<br />

10 Hard Surface Cleaners 2.5%<br />

11 Candle (Non-Skin/Incidental Skin) Limited<br />

Api <strong>QRA</strong> Worksop Jan 2007


<strong>QRA</strong> IMPLEMENTATION<br />

FUTURE FOCUS<br />

• 42 nd Amendment (2007) – about 40<br />

fragrance ingredients (new and existing)<br />

based on volume of use<br />

• 43 rd Amendment (2008) about 40<br />

fragrance ingredients (new and existing)<br />

• Key goal: to review by 2011 all chemically<br />

defined fragrance ingredients that have<br />

structural alerts <strong>for</strong> dermal sensitization<br />

that are used at greater than 1 metric ton<br />

per year on a worldwide basis.<br />

• Compliance with IFRA Standards (REXPAN(<br />

REXPAN)<br />

Api <strong>QRA</strong> Worksop Jan 2007


FUTURE <strong>QRA</strong> MEETINGS<br />

• Developments in Exposure-Based<br />

Quantitative Risk Assessment (<strong>QRA</strong>) <strong>for</strong><br />

Induction of <strong>Dermal</strong> <strong>Sensitization</strong> <strong>for</strong><br />

<strong>Fragrance</strong> <strong>Ingredient</strong>s Symposium-<br />

Wednesday March 28, 2007 1:30 PM.<br />

The Society of Toxicology Meeting,<br />

Charlotte, North Carolina, USA, March<br />

25-29, 2007.<br />

• 9 th Contact Dermatitis State-of-the-Art<br />

Issues, <strong>Fragrance</strong> Mini-Symposium<br />

Friday July 13, 2007, July 12-14, 2007,<br />

Hershey PA<br />

Api <strong>QRA</strong> Worksop Jan 2007

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!